COVID-19 Associated Mucormycosis: Ramping up our services during crisis.

Xess, Immaculata; Singh, Gagandeep; Yadav, Renu Kumari; Sachdev, Janya; Pandey, Mragnayani

Xess, Immaculata; Singh, Gagandeep; Yadav, Renu Kumari; Sachdev, Janya; Pandey, Mragnayani.

Xess I; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Singh G; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: drgagandeep@gmail.com.
Yadav RK; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Sachdev J; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Pandey M; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.

Indian J Med Microbiol ; 40(3): 470-471, 2022.

Article in English | MEDLINE | ID: covidwho-1768183

Subject(s)

COVID-19; Mucormycosis; Humans; Mucormycosis/diagnosis; Mucormycosis/drug therapy; Time Factors

Keywords

COVID; Diagnosis; Mucormycosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Mucormycosis Type of study: Diagnostic study Limits: Humans Language: English Journal: Indian J Med Microbiol Journal subject: Microbiology Year: 2022 Document Type: Article Affiliation country: J.ijmmb.2022.03.007

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google